ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
가상 생검 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 12.0%로 11억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 비용 효율적인 헬스케어 솔루션에 대한 관심 증가, 예방 의료에 대한 관심 증가, 맞춤형 의료에 대한 수요 증가, 최소 침습적 암 치료에 대한 관심 증가, 정밀 종양학에 대한 중요성 증가 등의 요인에 의해 이루어질 것으로 예측됩니다. 예측 기간의 주요 동향으로는 첨단 영상 센서의 개발, 멀티모달 생검 기술의 발전, 로봇 공학과의 통합을 통한 정확도 향상, 비침습적 바이오마커 검출의 혁신, 3차원(3D) 시각화 도구의 도입 등을 꼽을 수 있습니다.
종양학 질환의 유병률 증가는 향후 몇 년 동안 가상 생검 시장의 성장을 크게 촉진할 것으로 예측됩니다. 종양학 질환은 체내 세포의 비정상적인 증식 및 확산을 특징으로 하는 암 관련 건강 상태를 말합니다. 이러한 암 환자 증가는 식습관 장애, 운동 부족, 담배 소비, 환경 오염 물질에 대한 추가 노출과 같은 생활습관 요인에 기인합니다. 가상 생검은 기존의 조직 생검의 필요성을 최소화하면서 진단의 정확성과 환자의 안전성을 높이는 비침습적 실시간 영상 솔루션을 제공함으로써 이러한 질환의 진단과 모니터링을 지원합니다. 예를 들어, 2024년 7월 호주 보건 복지 연구소는 호주의 암 진단 건수가 2021년 15만 6,781건에서 2022년 16만 570건으로 3,789건 증가할 것이라고 보고했습니다. 그 결과, 종양성 질환의 발병률 증가는 가상 생검 시장 확대에 박차를 가하고 있습니다.
가상 생검 시장의 주요 업체들은 비침습적 진단의 정확성을 높이고 질병의 조기 발견과 맞춤 의료를 지원하기 위해 자기공명분광법(MRS) 플랫폼과 같은 첨단 기술의 개발 및 규제 당국의 승인을 우선순위에 두고 있습니다. 가상 생검을 지원하는 비침습적 이미징 방법으로, 실시간 질병 모니터링을 가능하게 하여 외과적 수술의 필요성을 제거합니다. 예를 들어, 2023년 11월 미국 헬스케어 기업 브레인스펙(BrainSpec Inc.)은 미국 식품의약국(FDA)으로부터 AI를 탑재한 브레인스펙(BrainSpec) 플랫폼에 대한 승인을 받았습니다. 이 플랫폼은 인공지능을 사용하여 MR 분광학 데이터를 분석하여 2-하이드록시글루타르산과 같은 뇌 대사물질을 검출하여 신경교종, 알츠하이머병, 다발성 경화증 진단을 위한 비침습적 가상 생검을 가능케 합니다. 이 시스템은 표준 MRI 스캐너와 통합되어 데이터 분석을 자동화하고, 몇 분 안에 결과를 제공하며, 뇌화학 참조 데이터베이스에 의존하여 진단의 신뢰성을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 가상 생검 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 가상 생검 시장 : 성장률 분석
세계의 가상 생검 시장 실적 : 규모와 성장, 2019-2024
세계의 가상 생검 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 가상 생검 전체 시장(TAM)
제6장 시장 세분화
세계의 가상 생검 시장 : 대상 치료 영역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
종양성 질환
신경 질환
심혈관 질환
안과 질환
내분비 질환
위장 장애
기타 타겟 치료 영역
세계의 가상 생검 시장 : 암 표적별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
고형 악성 종양
유방암
폐암
전립선암
대장암
뇌종양
기타 암 표적
세계의 가상 생검 시장 : 이미징 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
자기공명영상(MRI)
컴퓨터 단층촬영(CT)
X선
초음파
기타 영상 기술
세계의 가상 생검 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
연구기관 및 진단센터
기타 최종사용자
세계의 가상 생검 시장 : 종양성 질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
폐암
유방암
전립선암
대장암
간암
뇌종양
기타 암
세계의 가상 생검 시장 : 신경질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
알츠하이머병
파킨슨병
다발성 경화증
간질
뇌손상
뇌졸중
기타 신경질환
세계의 가상 생검 시장 : 심혈관질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
관상동맥 질환
심부전
부정맥
대동맥류
심장판막 막증
심근경색
기타 심혈관 질환
세계의 가상 생검 시장 : 안과 질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
노인성 황반변성
당뇨병 망막증
녹내장
망막 정맥 폐쇄증
백내장
기타 안질환
세계의 가상 생검 시장 : 내분비 질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
당뇨병
갑상선 질환
부신 질환
하수체 질환
부갑상선 질환
기타 내분비 질환
세계의 가상 생검 시장 소화기 질환 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
염증성 장질환
대장 폴립
위궤양
간경변
췌장 질환
간염
기타 위장 질환
세계의 가상 생검 시장 기타 타겟 치료 영역 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
근골격계 장애
신장 질환
폐 질환
혈액 질환
피부 질환
감염증
기타 제조건
제7장 지역별/국가별 분석
세계의 가상 생검 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 가상 생검 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
가상 생검 시장 : 경쟁 구도
가상 생검 시장 : 기업 개요
Canon Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
GE Healthcare : 개요, 제품 및 서비스, 전략 및 재무 분석
Quest Diagnostics Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Olympus Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Hologic Inc.
Illumina Inc.
Guardant Health Inc.
Esaote S.p.A
Samsung Medison Co Ltd.
Telix Pharmaceuticals Limited
Freenome Holdings Inc.
Perspectum Ltd.
QUIBIM S.L
IQ-AI Limited
BrainSpec Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
가상 생검 시장(2029년) : 새로운 기회를 제공하는 국가
가상 생검 시장(2029년) : 새로운 기회를 제공하는 부문
가상 생검 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Virtual biopsy is a non-invasive diagnostic method that leverages advanced imaging technologies and computer algorithms to analyze tissues for signs of disease. Its primary goal is to identify abnormalities, such as tumors or infections, without the need for traditional tissue sampling, minimizing risks and recovery time for patients. This technique is safer, faster, and less painful compared to conventional biopsies.
The main therapeutic areas targeted by virtual biopsy include oncology, neurology, cardiology, ophthalmology, endocrinology, gastroenterology, and other related conditions. Oncological disorders involve diseases characterized by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy is used for detecting a wide range of cancers, including solid tumors, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies utilized in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, among others, and are employed by end users such as hospitals, clinics, research institutes, diagnostic centers, and more.
The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides virtual biopsy market statistics, including the virtual biopsy industry's global market size, regional shares, competitors with the virtual biopsy market share, detailed virtual biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy market. This virtual biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to the increasing demand for non-invasive diagnostic techniques, a growing preference for early disease detection, enhanced efficiency in medical imaging software, greater patient convenience and comfort, and the expanding availability of telemedicine services.
The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The expected growth in the forecast period is driven by factors such as a greater focus on cost-effective healthcare solutions, an emphasis on preventive healthcare, increasing demand for personalized medicine, rising interest in minimally invasive cancer treatments, and the growing significance of precision oncology. Key trends in the forecast period include the development of advanced imaging sensors, the evolution of multimodal biopsy techniques, integration with robotics for enhanced precision, innovations in non-invasive biomarker detection, and the incorporation of three-dimensional (3D) visualization tools.
The increasing prevalence of oncological disorders is anticipated to significantly drive the growth of the virtual biopsy market in the coming years. Oncological disorders refer to cancer-related health conditions characterized by the abnormal growth and spread of cells within the body. This rise in cancer cases is largely attributed to lifestyle factors such as poor dietary habits, physical inactivity, tobacco consumption, and greater exposure to environmental pollutants. Virtual biopsy supports the diagnosis and monitoring of these disorders by offering non-invasive, real-time imaging solutions that minimize the need for traditional tissue biopsies while enhancing diagnostic precision and patient safety. For example, in July 2024, the Australian Institute of Health and Welfare reported that cancer diagnoses in Australia increased to 160,570 in 2022, up from 156,781 in 2021-an increase of 3,789 cases. As a result, the growing incidence of oncological disorders is fueling the expansion of the virtual biopsy market.
Key players in the virtual biopsy market are prioritizing the development of advanced technologies and regulatory approvals, such as magnetic resonance spectroscopy (MRS) platforms, to improve the accuracy of non-invasive diagnostics and support early disease detection and personalized care. MRS is a non-invasive imaging method that assists virtual biopsy by delivering detailed molecular information of tissues, enabling real-time disease monitoring and eliminating the need for surgical procedures. For instance, in November 2023, BrainSpec Inc., a U.S.-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its AI-powered BrainSpec platform. This platform analyzes MR spectroscopy data using artificial intelligence to detect brain metabolites such as 2-hydroxyglutarate, enabling non-invasive virtual biopsies for diagnosing gliomas, Alzheimer's disease, and multiple sclerosis. The system integrates with standard MRI scanners, automates data analysis, delivers results within minutes, and relies on a reference database of brain chemistry to improve diagnostic reliability.
In July 2022, Quibim S.L., a healthtech firm based in Spain, entered a partnership with Microsoft Corporation to develop artificial intelligence-powered virtual biopsy tools. This collaboration seeks to advance non-invasive diagnostic capabilities by merging Quibim's AI-based imaging solutions with Microsoft's Azure cloud infrastructure. The goal is to enhance disease detection accuracy and minimize dependence on conventional biopsy techniques. Microsoft Corporation, headquartered in the U.S., is a globally recognized technology company known for its software products and digital services.
Major players in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co. Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc., ImageBiopsy Lab GmbH, AI Metrics LLC, and Deep Bio Inc.
North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in virtual biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the virtual biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Virtual Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on virtual biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for virtual biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The virtual biopsy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Target Thrapeutic Areas: Oncological Disorders; Neurological Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Endocrine Disorders; Gastrointestinal Disorders; Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies; Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Cancer; Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging; Computed Tomography; X-Ray; Ultrasound; Other Imaging Technologies
4) By End Users: Hospitals And Clinics; Research Institutes And Diagnostic Centers; Other End Users
Subsegments:
1) By Oncological Disorders: Lung Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Liver Cancer; Brain Tumors; Other Cancers
2) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Brain Injuries; Stroke; Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease; Heart Failure; Arrhythmias; Aortic Aneurysm; Valvular Heart Disease; Myocardial Infarction; Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinal Vein Occlusion; Cataracts; Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus; Thyroid Disorders; Adrenal Gland Disorders; Pituitary Gland Disorders; Parathyroid Disorders; Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease; Colorectal Polyps; Gastric Ulcers; Liver Cirrhosis; Pancreatic Disorders; Hepatitis; Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders; Renal Disorders; Pulmonary Disorders; Hematologic Disorders; Dermatological Disorders; Infectious Diseases; Other Miscellaneous Conditions
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Virtual Biopsy Market Characteristics
3. Virtual Biopsy Market Trends And Strategies
4. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Virtual Biopsy Growth Analysis And Strategic Analysis Framework
5.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Virtual Biopsy Market Growth Rate Analysis
5.4. Global Virtual Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Virtual Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Virtual Biopsy Total Addressable Market (TAM)
6. Virtual Biopsy Market Segmentation
6.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncological Disorders
Neurological Disorders
Cardiovascular Disorders
Ophthalmological Disorders
Endocrine Disorders
Gastrointestinal Disorders
Other Target Therapeutic Areas
6.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Malignancies
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Cancer
Other Cancer Targeteds
6.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnetic Resonance Imaging
Computed Tomography
X-Ray
Ultrasound
Other Imaging Technologies
6.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Institutes And Diagnostic Centers
Other End Users
6.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Liver Cancer
Brain Tumors
Other Cancers
6.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Epilepsy
Brain Injuries
Stroke
Other Neurological Conditions
6.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coronary Artery Disease
Heart Failure
Arrhythmias
Aortic Aneurysm
Valvular Heart Disease
Myocardial Infarction
Other Cardiovascular Conditions
6.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Age-Related Macular Degeneration
Diabetic Retinopathy
Glaucoma
Retinal Vein Occlusion
Cataracts
Other Eye Disorders
6.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diabetes Mellitus
Thyroid Disorders
Adrenal Gland Disorders
Pituitary Gland Disorders
Parathyroid Disorders
Other Endocrine Conditions
6.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inflammatory Bowel Disease
Colorectal Polyps
Gastric Ulcers
Liver Cirrhosis
Pancreatic Disorders
Hepatitis
Other Gastrointestinal Conditions
6.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Musculoskeletal Disorders
Renal Disorders
Pulmonary Disorders
Hematologic Disorders
Dermatological Disorders
Infectious Diseases
Other Miscellaneous Conditions
7. Virtual Biopsy Market Regional And Country Analysis
7.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Virtual Biopsy Market
8.1. Asia-Pacific Virtual Biopsy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Virtual Biopsy Market
9.1. China Virtual Biopsy Market Overview
9.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Virtual Biopsy Market
10.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Virtual Biopsy Market
11.1. Japan Virtual Biopsy Market Overview
11.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Virtual Biopsy Market
12.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Virtual Biopsy Market
13.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Virtual Biopsy Market
14.1. South Korea Virtual Biopsy Market Overview
14.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Virtual Biopsy Market
15.1. Western Europe Virtual Biopsy Market Overview
15.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Virtual Biopsy Market
16.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Virtual Biopsy Market
17.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Virtual Biopsy Market
18.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Virtual Biopsy Market
19.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Virtual Biopsy Market
20.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Virtual Biopsy Market
21.1. Eastern Europe Virtual Biopsy Market Overview
21.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Virtual Biopsy Market
22.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Virtual Biopsy Market
23.1. North America Virtual Biopsy Market Overview
23.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Virtual Biopsy Market
24.1. USA Virtual Biopsy Market Overview
24.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Virtual Biopsy Market
25.1. Canada Virtual Biopsy Market Overview
25.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Virtual Biopsy Market
26.1. South America Virtual Biopsy Market Overview
26.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Virtual Biopsy Market
27.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Virtual Biopsy Market
28.1. Middle East Virtual Biopsy Market Overview
28.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Virtual Biopsy Market
29.1. Africa Virtual Biopsy Market Overview
29.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Virtual Biopsy Market Competitive Landscape And Company Profiles
30.1. Virtual Biopsy Market Competitive Landscape
30.2. Virtual Biopsy Market Company Profiles
30.2.1. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Virtual Biopsy Market Other Major And Innovative Companies
31.1. Hologic Inc.
31.2. Illumina Inc.
31.3. Guardant Health Inc.
31.4. Esaote S.p.A
31.5. Samsung Medison Co Ltd.
31.6. Telix Pharmaceuticals Limited
31.7. Freenome Holdings Inc.
31.8. Perspectum Ltd.
31.9. QUIBIM S.L
31.10. IQ-AI Limited
31.11. BrainSpec Inc.
32. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Virtual Biopsy Market
34. Recent Developments In The Virtual Biopsy Market
35. Virtual Biopsy Market High Potential Countries, Segments and Strategies
35.1 Virtual Biopsy Market In 2029 - Countries Offering Most New Opportunities
35.2 Virtual Biopsy Market In 2029 - Segments Offering Most New Opportunities
35.3 Virtual Biopsy Market In 2029 - Growth Strategies
